Therefore, increasing the activity of Nedd4 may be a therapeutic strategy in PD therapy; a Nedd4 activator named Ubv.N4.02 was found to improve ubiquitination by Nedd4 of its substrates [148,149]. This evidence concerns the gene NEDD4 and Parkinson disease.